Healthcare provider profile · identity verified

Garrett R Trobec, MD

Family Practice · SHOREVIEW, MN · NPI 1386655488

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	900	244
Lisinopril	Lisinopril	566	151
Amlodipine Besylate	Amlodipine Besylate	521	144
Losartan Potassium	Losartan Potassium	447	126
Rosuvastatin Calcium	Rosuvastatin Calcium	365	112
Metoprolol Succinate	Metoprolol Succinate	312	87
Omeprazole	Omeprazole	293	87
Hydrochlorothiazide	Hydrochlorothiazide	290	86
Levothyroxine Sodium	Levothyroxine Sodium	290	73
Simvastatin	Simvastatin	269	71
Tamsulosin Hcl	Tamsulosin Hcl	236	73
Pravastatin Sodium	Pravastatin Sodium	191	53
Metformin Hcl Er	Metformin Hcl	186	54
Eliquis	Apixaban	173	45
Allopurinol	Allopurinol	172	49
Trazodone Hcl	Trazodone Hcl	165	43
Alendronate Sodium	Alendronate Sodium	163	47
Gabapentin	Gabapentin	163	58
Metformin Hcl	Metformin Hcl	161	47
Glipizide Er	Glipizide	155	46
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	130	35
Atenolol	Atenolol	126	35
Metoprolol Tartrate	Metoprolol Tartrate	112	34
Pantoprazole Sodium	Pantoprazole Sodium	109	30
Zolpidem Tartrate	Zolpidem Tartrate	98	21
Furosemide	Furosemide	95	32
Ozempic	Semaglutide	94	20
Citalopram Hbr	Citalopram Hydrobromide	93	25
Sertraline Hcl	Sertraline Hcl	92	27
Pioglitazone Hcl	Pioglitazone Hcl	87	26
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	83	21
Jardiance	Empagliflozin	80	22
Xarelto	Rivaroxaban	76	23
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	75	18
Warfarin Sodium	Warfarin Sodium	75	18
Finasteride	Finasteride	69	19
Rybelsus	Semaglutide	65	16
Tramadol Hcl	Tramadol Hcl	65	14
Albuterol Sulfate Hfa	Albuterol Sulfate	63	25
Clopidogrel	Clopidogrel Bisulfate	63	17
Famotidine	Famotidine	59	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	59	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	59	16
Escitalopram Oxalate	Escitalopram Oxalate	58	15
Lorazepam	Lorazepam	55	suppressed
Prednisone	Prednisone	55	40
Amoxicillin	Amoxicillin	54	26
Oxycodone Hcl	Oxycodone Hcl	54	11
Bupropion Xl	Bupropion Hcl	48	13
Carvedilol	Carvedilol	46	13
Potassium Chloride	Potassium Chloride	45	15
Irbesartan	Irbesartan	43	suppressed
Ezetimibe	Ezetimibe	42	13
Fluticasone Propionate	Fluticasone Propionate	42	17
Glipizide	Glipizide	39	suppressed
Duloxetine Hcl	Duloxetine Hcl	38	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	37	11
Venlafaxine Hcl Er	Venlafaxine Hcl	37	suppressed
Montelukast Sodium	Montelukast Sodium	36	11
Alprazolam	Alprazolam	34	13
Propranolol Hcl Er	Propranolol Hcl	33	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	32	suppressed
Pregabalin	Pregabalin	31	suppressed
Meloxicam	Meloxicam	30	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	30	suppressed
Clonazepam	Clonazepam	29	suppressed
Lovastatin	Lovastatin	29	suppressed
Lansoprazole	Lansoprazole	26	suppressed
Celecoxib	Celecoxib	25	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	25	suppressed
Ondansetron Hcl	Ondansetron Hcl	25	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	25	25
Azithromycin	Azithromycin	24	17
Buspirone Hcl	Buspirone Hcl	24	suppressed
Cephalexin	Cephalexin	24	21
Fluvoxamine Maleate	Fluvoxamine Maleate	24	suppressed
Testosterone Cypionate	Testosterone Cypionate	24	suppressed
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Mounjaro	Tirzepatide	22	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	22	suppressed
Estradiol	Estradiol	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Acyclovir	Acyclovir	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Nitroglycerin	Nitroglycerin	19	15
Methocarbamol	Methocarbamol	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Spironolactone	Spironolactone	18	suppressed
Valsartan	Valsartan	18	suppressed
Diazepam	Diazepam	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	14
Valacyclovir	Valacyclovir Hcl	17	suppressed
Dutasteride	Dutasteride	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	14
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Cefdinir	Cefdinir	14	13
Donepezil Hcl	Donepezil Hcl	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	13	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	13	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	suppressed
Balsalazide Disodium	Balsalazide Disodium	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Dextroamphetamine Sulfate Er	Dextroamphetamine Sulfate	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Mercaptopurine	Mercaptopurine	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Phenytoin	Phenytoin	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Potassium Citrate Er	Potassium Citrate	12	suppressed
Dilantin	Phenytoin Sodium Extended	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error